RECRUITING

The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,

Official Title

The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

Quick Facts

Study Start:2022-07-05
Study Completion:2031-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05791786

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * The inability of an individual to provide a signed and dated informed consent form or those who do not wish to participate.

Contacts and Locations

Study Contact

Miranda Klassen
CONTACT
760-444-5505
miranda@afesupport.org
Irene Stafford, MD
CONTACT
713-500-6412
irene.stafford@uth.tmc.edu

Principal Investigator

Irene Stafford, MD
PRINCIPAL_INVESTIGATOR
UT Health Science Center Health Science Center

Study Locations (Sites)

The University of Texas Health Science Center at Houston
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • Irene Stafford, MD, PRINCIPAL_INVESTIGATOR, UT Health Science Center Health Science Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-05
Study Completion Date2031-12-31

Study Record Updates

Study Start Date2022-07-05
Study Completion Date2031-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Amniotic Fluid Embolism